Eli Lilly and Company vs Pfizer Inc.
Side-by-side earnings signal comparison from SEC quarterly filings
Verdict
Eli Lilly and Company (LLY) carries a "Tailwind" signal with +73.1% revenue growth, while Pfizer Inc. (PFE) is "Neutral" with -18.4% revenue growth. Both companies report in the Healthcare sector.
| Metric | Eli Lilly and Company (LLY) | Pfizer Inc. (PFE) |
|---|---|---|
| Operator Signal | Tailwind | Neutral |
| Signal Confidence | HIGH | HIGH |
| Latest Revenue | $19.8B | $14.5B |
| Revenue Growth | 73.1%* | -18.4% |
| Latest EPS | $8.26* | $0.47 |
| EPS Growth | 672.0%* | -39.7% |
| Sector | Healthcare | Healthcare |
| Quarters Tracked | 8 | 8 |
Eli Lilly and Company (LLY) carries a "Tailwind" signal with +73.1% revenue growth, while Pfizer Inc. (PFE) is "Neutral" with -18.4% revenue growth. Both companies report in the Healthcare sector.